Accumulating studies have revealed increasing serum levels of IL-34 in coronary artery disease (CAD) patients, and IL-34 can predict major adverse cardiovascular events in AMI patients, as well as the prognosis and severity of ischemic cardiomyopathy patients and ischemic stroke patients [4–8]. Here, IL34 is linked to coronary artery disorder.